Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Discover Which Cryptocurrency Is Best To Start 2024 using a straightforward framework to compare potential coins and make a confident choice.
23,369 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
A California federal court weighs a landmark supply-chain risk dispute between Anthropic and the Department of War, w...
Investors are weighing a shift from high-growth tech to more income-driven energy plays as AI-era capex creates uncer...
Progressive lawmakers unveiled a bill to halt new data centers for two years while federal safeguards for energy, lab...
SoFi stock faces a controversial short-seller narrative. This guide explains what that means, how to evaluate the cla...
Bitcoin holds near $70,000 as macro pressures and tight liquidity push price into a narrow range ahead of a potential...
A viral parody drawing 110 million views isn’t just a pop culture moment—it also tests money decisions. This guide sh...
MSFW has fallen sharply since its July 2025 launch, while weekly payouts crater from a peak of $0.97 to a recent $0.1...
Bank Of America upgrades TripAdvisor to Buy, signaling potential value from Viator and TheFork as Starboard Value exp...
Workers say their benefits aren’t safety nets but leverage points used to keep them in place. This timely report expl...
Amazon launches a $200 billion AI-focused capex plan for 2026, with Trainium and Anthropic in the mix. Here’s what in...
Ethereum presses against a $2,400 resistance as institutional buyers accumulate and BitMine builds a sizable ETH stak...